"Trump Imposes High Trade Tariffs on Switzerland: Exploring the Reasons Behind the 39% Rate"
The United States has imposed a high 39% tariff on Swiss imports, significantly higher than the 15% tariffs applied to EU and Japanese imports. This decision, which is one of the highest globally for imports from a developed country, is primarily due to political and trade negotiation failures.
Professor Thomas Cottier, emeritus of European and International Economic Law at the University of Bern, has stated that he is convinced the tariffs are illegal and violate the rules of the World Trade Organisation (WTO).
The tariffs were imposed unilaterally after negotiations between Swiss officials, including President Karin Keller-Sutter, and US representatives failed to produce an agreement to avoid or lower the tariffs. Unlike other countries such as EU members and Japan, Switzerland was not able to offer concessions or agreements that resulted in lower tariff rates.
The high tariff reflects US concerns over the trade deficit with Switzerland and appears designed to pressure Switzerland into making concessions. Certain Swiss sectors are specifically targeted, such as the watchmaking, tech, mechanical engineering, cheese, and chocolate industries, which are significant exports to the US. The US is the largest single market for Swiss watches, accounting for around 20% of Swiss watch exports, so the tariff imposes a strong disadvantage to Swiss manufacturers against competitors from countries with lower tariffs.
Economist Adrian Prettejohn at Capital Economics believes the high tariff rate may be negotiated down in the future. An agreement with Switzerland is still possible, according to US finance minister Scott Bessent, suggesting negotiations could take place before the tariffs come into effect on August 7th.
In a positive development, pharmaceutical goods are currently exempt from the tariffs imposed on Swiss imports. However, accusations of currency manipulation by the Swiss National Bank are a possibility. Switzerland could file a complaint with the WTO if negotiations fail, but it may not be able to exert pressure on the US on its own, as other countries are unlikely to join in support.
Despite the high tariffs, the trade balance between the US and Switzerland was heavily in Switzerland's favor at 40 billion Swiss francs last year. This underscores the potential economic impact of the tariffs on both countries.
The tariffs have led to significant investments by Swiss pharmaceutical giants Roche and Novartis in the United States to avoid potential tariffs. Meanwhile, Swiss president Karin Keller-Sutter spoke with Trump on Thursday and wrote that the trade deficit remains the center of Trump's preoccupation.
Trump issued an ultimatum to the heads of 17 major pharmaceutical companies, giving them 60 days to lower drug prices or face consequences. This move, coupled with the high tariffs on Swiss imports, indicates a broader US strategy to address trade imbalances and pressure foreign countries into making concessions.
In conclusion, the high 39% tariff on Swiss imports is a result of political and trade negotiation failures, with the US opting for a punitive tariff level to address trade concerns and gain leverage over Swiss trade policy, rather than a mutually agreed tariff rate. The situation is dynamic, and negotiations between the two countries continue, with potential implications for both economies.
- The high tariff rate imposed on Swiss imports, primarily in sectors such as watchmaking, tech, mechanical engineering, cheese, and chocolate, raises concerns within the finance industry, as it could potentially impede financial growth for Swiss manufacturers.
- The ongoing negotiations between the US and Switzerland in regard to the tariffs have sparked discussions in general-news and politics, with implications for trade relations and economic stability between the two countries.
